Three Induction Treatments on Cryptococcal Meningitis
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Three induction treatment strategies [ voriconazole +5FC vs. amphotericin deoxycholate
(0.4-0.5 mg/kg/d)+5FC vs. amphotericin deoxycholate (0.7-1.0 mg/kg/d)+5FC ] for HIV-infected
patients with cryptococcal meningitis were compared.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Collaborator:
Wenzhou Central Hospital
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B Voriconazole